AKT2 Is Frequently Upregulated in HER-2/neu-positive Breast Cancers and May Contribute to Tumor Aggressiveness by Enhancing Cell Survival

Oncogene - United Kingdom
doi 10.1038/sj.onc.1205438
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas Without HER-2/neu Gene Amplification

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2003English

Dystroglycan Expression Is Frequently Reduced in Human Breast and Colon Cancers and Is Associated With Tumor Progression

American Journal of Pathology
Forensic MedicinePathology
2003English

Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer

Medical Journal Armed Forces India
Medicine
2008English

Amplification of Her-2/Neu Gene in Her-2/Neu-Overexpressing and -Nonexpressing Breast Carcinomas and Their Synchronous Benign, Premalignant, and Metastatic Lesions Detected by FISH in Archival Material

Modern Pathology
Forensic MedicinePathology
2002English

Immunohistochemical Evaluation of Her-2/Neu Overexpression in Breast Carcinoma in Mosul

Annals of the College of Medicine, Mosul
2008English

Treatment of HER-2/neu Overexpressing Breast Cancer Xenograft Models With Trastuzumab (Herceptin) and Gefitinib (ZD1839): Drug Combination Effects on Tumor Growth, HER-2/neu and Epidermal Growth Factor Receptor Expression, and Viable Hypoxic Cell Fraction

Clinical Cancer Research
Cancer ResearchOncology
2004English

Reduction in HER-2 Protein Expression in a Breast Tumor HER-2 Positive After Only One Injection of Trastuzumab: A Case Report

Cases Journal
2009English

Chemosensitization of HER-2/neu-overexpressing Human Breast Cancer Cells to Paclitaxel (Taxol) by Adenovirus Type 5 E1A

Oncogene
Cancer ResearchGeneticsMolecular Biology
1997English

Comparison of the Efficacy and Survival Analysis of Neoadjuvant Chemotherapy for Her-2-Positive Breast Cancer

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy